0001552451-15-000002.txt : 20150430 0001552451-15-000002.hdr.sgml : 20150430 20150430131440 ACCESSION NUMBER: 0001552451-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150430 DATE AS OF CHANGE: 20150430 EFFECTIVENESS DATE: 20150430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MyoKardia Inc CENTRAL INDEX KEY: 0001552451 IRS NUMBER: 455500552 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-238915 FILM NUMBER: 15816891 BUSINESS ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-741-0900 MAIL ADDRESS: STREET 1: 333 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0707 D LIVE 0001552451 MyoKardia Inc 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-741-0900 DELAWARE None None Corporation true 2012 Charles Homcy 333 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Director Kevin Starr 333 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Director Mark Perry 333 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Director Katherine Bowdish 333 Allerton Avenue Suite 102 South San Francisco CA CALIFORNIA 94080 Director Tassos Anastasios Gianakakos 333 Allerton Avenue South San Francisco CA CALIFORNIA 94080 Executive Officer Director Biotechnology Decline to Disclose 06b false 2015-04-20 false true false 0 46000001 46000001 0 false 9 0 0 0 true The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business. false MyoKardia Inc /s/ T. Anastasios Gianakakos T. Anastasios Gianakakos CEO and President 2015-04-28